Metabolomics and proteomics analyses revealed mechanistic insights on the antimicrobial activity of epigallocatechin gallate against Streptococcus suis
Authors:
Open Access
- 20 September 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 973282
Abstract
Streptococcus suis (S. suis) is a highly virulent zoonotic pathogen and causes severe economic losses to the swine industry worldwide. Public health security is also threatened by the rapidly growing antimicrobial resistance in S. suis. Therefore, there is an urgent need to develop new and safe antibacterial alternatives against S. suis. The green tea polyphenol epigallocatechin gallate (EGCG) with a number of potential health benefits is known for its antibacterial effect; however, the mechanism of its bactericidal action remains unclear. In the present, EGCG at minimal inhibitory concentration (MIC) showed significant inhibitory effects on S. suis growth, hemolytic activity, and biofilm formation, and caused damage to S. suis cells in vitro. EGCG also reduced S. suis pathogenicity in Galleria mellonella larvae in vivo. Metabolomics and proteomics analyses were performed to investigate the underlying mechanism of antibacterial activity of EGCG at MIC. Many differentially expressed proteins involved in DNA replication, synthesis of cell wall, and cell membrane, and virulence were down-regulated after the treatment of S. suis with EGCG. EGCG not only significantly reduced the hemolytic activity of S. suis but also down-regulated the expression of suilysin (Sly). The top three shared KEGG pathways between metabolomics and proteomics analysis were ABC transporters, glycolysis/gluconeogenesis, and aminoacyl-tRNA biosynthesis. Taken together, these data suggest that EGCG could be a potential phytochemical compound for treating S. suis infection.Keywords
This publication has 47 references indexed in Scilit:
- Green tea extract and its major constituent epigallocatechin-3-gallate inhibit growth and halitosis-related properties of Solobacterium mooreiBMC Complementary and Alternative Medicine, 2015
- Mechanism for the antibacterial action of epigallocatechin gallate (EGCg) on Bacillus subtilisBioscience, Biotechnology, and Biochemistry, 2015
- The antimicrobial possibilities of green teaFrontiers in Microbiology, 2014
- The Contribution of Suilysin to the Pathogenesis of Streptococcus suis MeningitisThe Journal of Infectious Diseases, 2013
- Galleria mellonellalarvae as an infection model for group A streptococcusVirulence, 2013
- Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green teaBritish Journal of Pharmacology, 2012
- Streptococcus suis, an Emerging Drug-Resistant Animal and Human PathogenFrontiers in Microbiology, 2011
- Identification ofStreptococcus suisgenes preferentially expressed under iron starvation by selective capture of transcribed sequencesFEMS Microbiology Letters, 2009
- In vitro antimicrobial susceptibility of Streptococcus suis strains isolated from clinically healthy sows in ChinaVeterinary Microbiology, 2008
- Streptococcus suis: an emerging zoonotic pathogenThe Lancet Infectious Diseases, 2007